Skip to content
Minnetronix Medical
February 15, 2021 | Minnetronix Medical

Minnetronix AI experts join clinician collaborators to share how AI can improve stroke treatment

Sign up for free March 8 web event from University of Minnesota featuring Minnetronix experts.

Read Article
February 8, 2021 | Presentations and Publications

Seeking a revolution in clinical care through AI

Minnetronix shares its experience in applying AI and machine learning to medical devices.

Read Article
February 3, 2021 | Minnetronix Medical

Minnetronix Medical Announces Recapitalization with Altaris Capital Partners

Minnetronix announces a majority recapitalization with Altaris Capital Partners, an investment firm focused on the healthcare industry.

Read Article
November 20, 2020 | Prairie Business

Wearable Medical Technology

Minnetronix Medical General Manager Jim Reed interviewed about the future of medical device wearables.

Read Article
October 20, 2020 | Minnetronix Medical

Minnetronix Medical Awarded National Institutes of Health Grant for Proprietary Neurapheresis Product that Removes Blood from Spinal Fluid

Fast Track Small Business Innovation Research Funding Accelerates Minnetronix’s Platform Strategy to Bring Adaptable Technology and Market-Ready Products to Customers

Read Article
  • 1
  • 2
  • 3
  • …
  • 9
  • »

Minnetronix Medical
1635 Energy Park Drive
St. Paul, MN 55108
P: 651-917-4060
neuro@minnetronixmedical.com

Minnetronix is a trademark of Minnetronix Medical, Inc. MindsEye is a trademark of Minnetronix Neuro, Inc.
Caution: Federal (U.S.A.) Law restricts this device to sale by or on the order of a physician.

Neurapheresis is a trademark of Minnetronix, Inc.
Caution: Investigational Device. Limited by Federal (U.S.A.) law to investigational use only.

DepiCT is a trademark of Minnetronix Neuro, Inc.
DepiCT Neuroimaging Platform is currently under development. All subsequent material represents intended use.

LinkedIn Facebook Twitter Twitter
© 2025 Minnetronix Medical. All rights reserved.